WGS Competitors & Alternatives
Compare GeneDx Holdings Corp. with similar stocks in the same industry
Diagnostics & Research
WGS
Main Stock$63.85
Tradestie Score
54
Market Cap
$3.26B
Revenue Growth
0.2%
Analyst Upside
+22.9%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VCYT
Veracyte, Inc.
|
$57.48
|
$2.85B | 52.8 | 61 | Compare |
|
SEZL
Sezzle Inc. Common Stock
|
$160.25
|
$2.68B | 38.2 | 60 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$71.80
|
$2.24B | - | 62 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.02
|
$2.22B | - | 59 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$90.35
|
$1.77B | - | 52 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$16.14
|
$1.42B | - | 64 | Compare |
|
NEOG
Neogen Corp
|
$9.65
|
$1.26B | - | 61 | Compare |
|
OPK
Opko Health Inc.
|
$1.23
|
$1.23B | - | 56 | Compare |
|
NEO
NeoGenomics, Inc.
|
$14.11
|
$1.13B | - | 58 | Compare |
|
CDNA
CareDx, Inc.
|
$28.76
|
$798.40M | - | 61 | Compare |
More WGS Analysis
Data updated: Jul 13, 2026 | Industry: Diagnostics & Research (SIC 8000)
37 stocks in this industry